Babraham Research Campus Tenant

Please click here for location map.

	Alpha Biologics Alpha Biologics is an independent contract biomanufacturing organisation offering FDA/EMEA cGMP compliant services to the worldwide pharmaceutical and biotechnology industry.
	Amura
	ASM Scientific Ltd
	Babraham Bioscience Technologies Limited Babraham Bioscience Technologies Ltd (BBT) is the wholly owned trading company of the Babraham Institute and is the pro-active vehicle through which all commercial opportunities on the Babraham Research Campus are planned and delivered.
	Babraham Institute The Institute is an independent charitable life sciences institute, sponsored by the Biotechnology and Biological Sciences Research Council. It undertakes world-leading innovative research and advanced training with relevance to the biomedical, biotechnological, pharmaceutical and healthcare communities. The commercialisation of the Institute's research is managed by its wholly-owned trading subsidiary, Babraham Bioscience Technologies Ltd (BBT), a knowledge transfer company, which also manages a BioIncubator facility for small biotech companies. The Babraham Institute, BBT and a number of independent biomedical and biotechnology companies are situated on the Babraham Research Campus, located six miles south-east of Cambridge. Set in the picturesque parkland estate of Babraham Hall, the campus provides an environment that promotes innovation in the biomedical sector and has key role in the development of the Eastern region's biotechnology community.
	Colonix Medical Limited
	EESCN
	ERBI Networking and communications in Cambridge and the East of England Bio-community. Our aim is to enhance the growth and development of biotechnology and medtech in the East of England, thereby asserting the region as a world renowned centre of excellence
	Horizon Discovery Horizon Discovery is a translational genomics company founded in June 2007 and is headquartered at the IQ Cambridge Campus, Cambridge, UK and with additional research laboratories in Torino, Italy. The company supplies a wide range of products and services based on Human isogenic cell-lines, which represent accurate models of defined cancer patient populations and their matched normal genetic backgrounds – a missing link in the rational and efficient development of novel targeted anti-cancer agents. The company has unique IP in the field of gene engineering and is developing new IP via in-house and collaborative drug discovery programs.
	Innova Biosciences Ltd Innova specialises in bioconjugate technology and has recently launched Lightning-Link, a method for labelling biomolecules requiring only 30 seconds hands-on time.
	MedCell Bioscience Ltd MedCell Bioscience is a UK based biotech company focussed on harnessing the power of stem cells to provide musculoskeletal regenerative therapeutics. MedCell was formed in September 2002 as a spin-out from the Institute for Orthopaedics and Musculoskeletal Science (IOMS) and the Royal Veterinary College (RVC) to develop technology for the treatment of tendon and ligament injuries using adult stem cells. In June 2008 MedCell merged with NovaThera to create a company with the breadth of technologies to become a key player in the regenerative medicine market.
	Novexin Novexin is a biotechnology company developing new technologies with potential to radically change the way in which proteins are produced, particularly proteins of pharmaceutical importance.
	Phico Therapeutics Limited
	Population Genetics Technologies Limited PGT is a start-up company focused on changing paradigms for performing large-scale population genetics studies. The company is seeking to recruit a Director of Business Development to play a key role in identifying, choosing, and then executing on the specific market opportunities that PGT will pursue.
	Senexis Senexis is a growing, small-molecule drug development company that is committed to revolutionising the treatment and diagnosis of diseases resulting from the inevitable process of ageing. Senexis is advancing a pipeline of novel treatments for diseases resulting from the toxicity of amyloid-like proteins.
	Stem Cell Sciences Ltd Stem Cell Sciences’ core objective is to develop safe and effective stem cell-based therapies for currently incurable diseases.
	Translocus Ltd

About this section

Our know-who directory enables you to find the people/companies you need to know in Cambridge. Discover more about the wide range of members of the Cambridge Network including large multinationals, startups, academics, independent advisors, students and charity organisations. - Make sure your own entry is up to date!

Organisation Key

	Founder
	Founder Member
	Corporate Member 1-5 staff
	Corporate Member 6-20 staff
	Corporate Member 21-50 staff
	Corporate Member 51-100 staff
	Corporate Member 100 plus staff
	Individual Member
	Academic Organisation below 100 staff
	Charity below 100 staff
	Cambridge University Spin Out
	Babraham Research Campus Tenant
	St John's Innovation Centre tenant